Andrew Long Email & Phone Number

New York, Ny, Us

Morrisville, Nc, Us

Morrisville, Nc, Us

Built on the combination of Campbell Alliance and Kinapse, Syneos Health Consulting is a leading management consulting firm specializing in the life sciences industry and is a part of Syneos Health, the only fully integrated end-to-end clinical and commercial solution organization. We provide deep subject matter expertise over the entire lifecycle of an organization, portfolio or asset and our unique ability to leverage end-to-end capabilities and global functional and therapeutic experts results in highly customized solutions. Deep pre- and post-launch expertise generates strategic insights that yield implementation-focused recommendations designed to reduce risk, speed time to market and increase overall asset and portfolio value.

Advise investment banks and private equity groups as well as develop strategic initiatives for large and growing pharmaceutical, biotech, and medical device companies in the US, Europe, and Asia. Experience managing teams of 5+ consultants in deliverable execution. Focused on revenue forecasting and valuations, extensive quantitative and qualitative primary research initiatives, scientific literature review, US and EU market access, acquisition and licensing activity, royalty investments, and fundraising rounds.Selected Accomplishments:• Built a worldwide top-line revenue forecasting model for an international healthcare investment bank interested in investing in a potentially multi-billion dollar oncology treatment in a rapidly changing and complex treatment area.• Built a revenue forecasting and valuation model for a top 20 biopharmaceutical company and provided launch and clinical development strategy recommendations based on developed financial projections in multiple diabetes-related indications for a potentially multi-billion dollar product• Developed and maintained a revenue forecasting and valuation model for an early stage biotech company based in China launching 505(b)2 products in the US and performed key BD outreach aiding the company in actualizing acquisition of its primary assets. Developed risk-adjusted NPV estimates accounting for Chinese and US market trends.• Provided policy trend analysis in the US surrounding the ACA and industry-wide M&A activity aiding a multibillion dollar pharmaceutical company’s chief strategy officer in adjusting company wide forecasts through 2021• Evaluated best practice distribution activities of high-cost, cold-storage biologics to aid a worldwide top 20 pharma firm in upgrading its distribution practices

Raleigh, North Carolina, Us

Developed strategic initiatives for top pharmaceutical and biotech firms throughout the world. As a Consultant-level (similar to Associate-level) member of the Corporate Development Center of Excellence, specialized in the following: Corporate Strategy, Portfolio Strategy, Emerging Market Strategy, Investment Strategy, Business Development, Forecasting, Valuations, Acquisitions and Licenses, Post-Acquisition Integration, and RestructuringSelected Accomplishments:• Evaluated a $1 billion+ generic pharmaceutical manufacturer for acquisition by a major private equity firm by assessing the current state of the US generic market and helping build forecasts for top earning products. Developed key formulas based on the generic competitive landscape in the US to drive financial forecasts of 20+ products.• Conducted a global opportunity assessment for a biosimilar product in the anti-inflammatory space for an early stage biotechnology company. Provided market entry strategies for 30+ major markets. Maintained forecast model for 6+ indications in 30+ markets.• Developed and maintained a database of all pharmaceutical products in five major therapeutic areas supporting the selection and evaluation of key assets and companies for acquisition by a multibillion dollar pharmaceutical manufacturer• Performed a high level market assessment of the animal health market and reviewed a top animal health company’s R&D capabilities to make recommendations for consolidation of it’s R&D site network

Secaucus, Nj, Us

• Created six proposals to enter markets in four disease areas the company did not currently lead in through acquisitions, partnerships, and licensing deals• Performed strategic research and financial analysis at company and industry levels aiding in creation of BD proposals• Received approval from senior management to move to next stages in acquisition proposal that could increase company revenue by $1.5 billion• Reported directly to VP of Business Development

New York, Ny, Us

• Performed litigation tasks - drafted and served motions, conducted research on potential clients/matters, and prepared hearing materials for 15 partners and 10 associates, as sole paralegal in Finance and Insolvency departments• Clients included numerous Fortune 100 energy, banking, and healthcare institutions

New York, New York, Us

• Conducted employee reviews identifying employees not reaching exemplary standards of the firm

Arlington, Virginia, Us

• Performed strategic research and data collection in several areas including civil asset forfeiture, vending regulations, and defamation• Received training in legal writing, client relations, and public relations from attorneys of all levels of experience in public and private forums

Master Of Business Administration (M.B.A.), Finance

Bachelor’S Degree, Psychology

2019 Level Ii Candidate In The Cfa Program